Recent advancement of imidazolate framework (ZIF-8) based nanoformulations for synergistic tumor therapy

Nanoscale. 2019 Nov 28;11(44):21030-21045. doi: 10.1039/c9nr06558j. Epub 2019 Nov 1.

Abstract

As a new kind of porous material, zeolitic imidazolate frameworks (ZIF-8) are built from zinc ions and 2-methylimidazolate and possess unique merits including high porosity, good structural regularity and tunability, adjustable surface functionality and intrinsic pH induced biodegradability. These advantages endow ZIF-8 with multiple functionalities and stimuli-responsive controlled release of loaded payloads by endogenous or exogenous means. In this review, we will summarize the recent advancement of ZIF-8 as nanocarriers for the loading of various molecules including chemotherapeutic drugs, photosensitizers, photothermal agents, and proteins to fabricate multifunctional nanocomposites for synergistic cancer therapy. In addition, the challenges and future developments in this area will be highlighted.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / therapeutic use
  • Delayed-Action Preparations / chemistry
  • Delayed-Action Preparations / therapeutic use
  • Drug Carriers* / chemistry
  • Drug Carriers* / therapeutic use
  • Humans
  • Imidazoles* / chemistry
  • Imidazoles* / therapeutic use
  • Nanocomposites* / chemistry
  • Nanocomposites* / therapeutic use
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Portraits as Topic
  • Zeolites* / chemistry
  • Zeolites* / therapeutic use

Substances

  • Antineoplastic Agents
  • Delayed-Action Preparations
  • Drug Carriers
  • Imidazoles
  • Zeolites
  • imidazole